Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery

Pharmaceutical Research

Volumn 16, Issue 12, 1999, Pages 1818-1824

  Laneri, Sonia ^a   Sacchi, Antonia ^a   Di Frassello, Enrico Abignente ^a   Luraschi, Elena ^a   Colombo, Paolo ^b   Santi, Patrizia ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

DHEA; Iontophoresis; Prodrug; Skin; Transdermal

Indexed keywords

PRASTERONE; PRODRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TRANSPORT; HYDROLYSIS; IONIZATION; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033451817     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018991023618     Document Type: Article

References (15)

1. R. R. Watson, A. Huls, M. Araghinikuam, and S. Chung. Dehydroepiandrosterone and diseases of aging. Drugs-Aging 9:274-291 (1996).
2. A. J. Morales, J. J. Nolan, J. C. Nelson, and S. S. Yen. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78; 1360-7 (1994).
3. J. E. Buster, P. R. Casson, A. B. Straughn, D. Dale, E. S. Umstot, N. Chiamori, and G. E. Abraham. Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies. Am. J. Obstet. Gynecol. 166; 1163-8 (1992).
4. J. Y. Yang, A. Schwartz, and E. E. Henderson. Inhibition of HIV-I latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res. Hum. Retroviruses 9:747-54 (1993).
5. K. T. Khaw. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J. Endocrinol. 150:S149-153 (1996).
6. O. M. Wolkowitz, V. I. Reus, E. Roberts, F. Manfredi, T. Chan, W. J. Raum, S. Ormiston, R. Johnson, J. Canick, L. Brizendine, and H. Weingartner. Dehydroepiandrosterone (DHEA) treatment of depression. Biol.-Psychiatry 41:311-318 (1997).
7. P. R. Casson, S. A. Carson, and J. E. Buster. Replacement of dehydroepiandrosterone in the elderly: rationale and prospects for the future. Endocrinologist 8:187-194 (1998).
8. A. Kim, P. G. Green, G, Rao, and R. H. Guy. Convective solvent flow across the skin during iontophoresis. Pharm. Res. 10: 1315-1320 (1993).
9. P. G. Green, R. S. Hinz, A. Kim, E C. Szoka, and R. H. Guy. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm. Res. 8: 1121-1127 (1991).
10. L. Z. Benet and J. E. Goyan, Potentiometric determination of dissociation constants. J. Pharm. Sci. 56:665-680 (1967).
11. P. Santi, P. L. Catellani, P. Colombo, C. Ringard-Lefebvre, C. Barthélémy, and A. M. Guyot-Hermann. Partition and transport of verapamil and nicotine through artificial membranes. Int. J. Pharm. 68:43-49 (1991).
12. J. Hirvonen, J. H. Rytting, P. Paronen, and A. Urtti. Dodecyl N,N-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin. Pharm. Res. 8:933-937 (1991).
13. P. Colombo and P. Santi. Metodo ionoforetico per la somministrazione di farmaci e composizione farmaceutica solida per la sua realizzazione, Italian Patent Application, MI94A002047 (1994).
14. J. Boehnlein, A. Sakr, J. L. Lichtin, and R. L. Bronaugh. Characterization of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinyl palmitate to retinol (Vitamin A) during percutaneous absorption. Pharm. Res. 11: 1155-1159 (1994).
15. C. C. Cullander. What are the pathways of iontophoretic current flow through mammalian skin? Adv. Drug Del. Rev. 9:119-135 (1992).